William L. Macias - Apr 19, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Medical Officer
Signature: /s/ Eva Renee Barnett, attorney-in-fact for William L. Macias
Stock symbol: IMVT
Transactions as of: Apr 19, 2022
Transactions value $: -$6,932
Form type: 4
Date filed: 4/20/2022, 04:34 PM
Previous filing: Jan 7, 2022
Next filing: Jul 26, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	-$6.93K	-1.39K	-0.71%	$4.98^*	196K	Apr 19, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 25% of these RSUs vested on April 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Content

On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 25% of these RSUs vested on April 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.